Figure 4From: VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO) Survival analysis under FLP treatment for patients older than 60Â years. A. VEGF-R3 and B. CXCR4 expression in an observation period of 5Â years.Back to article page